The "Art" of Medicine and The "Smokescreen" of the Randomized Trial Off-Label Use of Vascular Devices

被引:5
作者
Ansel, Gary M. [1 ]
Jaff, Michael R. [2 ]
机构
[1] Univ Toledo, Sch Med, Ctr Crit Limb Care, Riverside Methodist Hosp, Columbus, OH 43214 USA
[2] Massachusetts Gen Hosp, Dept Med, Vasc Ctr, Div Cardiol Vasc Med, Boston, MA 02114 USA
关键词
peripheral vascular disease; stent; angioplasty; regulatory; off-label;
D O I
10.1002/ccd.21776
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Once a device is approved for sale in the United States by the Food and Drug Administration (FDA), it can legally be used by doctors to treat any condition a physician determines is medically appropriate. Based on postmarket published data and physician procedural experience, this may even become the standard of care when an alternative device either does not exist or is inferior in performance, even before FDA approval. This right of physicians to practice medicine without FDA approval is Federal law. The off-label use of medical devices for the treatment of peripheral vascular disease has recently become the latest target by groups with interests that have little to do with patient care. This interference has begun to negatively impact the latitude necessary for physicians to best treat their patients. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:998 / 1002
页数:5
相关论文
共 50 条
  • [31] Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications
    Mathevula, Hlayiseka
    Schellack, Natalie
    Orubu, Samuel
    Godman, Brian
    Matlala, Moliehi
    PHARMACY, 2023, 11 (06)
  • [32] Off-label and unlicenced medicine administration to paediatric emergency department patients
    Taylor, David Mcd
    Joffe, Paul
    Taylor, Simone E.
    Jones, Alicia
    Cheek, John A.
    Craig, Simon S.
    Graudins, Andis
    Dhir, Reetika
    Krieser, David
    Babl, Franz E.
    EMERGENCY MEDICINE AUSTRALASIA, 2015, 27 (05) : 431 - 437
  • [33] Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population
    Pesiou, Stella
    Barcelo, Rafel
    Papazisis, Georgios
    Torres, Ferran
    Pontes, Caridad
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] In-label and off-label use of respiratory drugs in the Italian paediatric population
    Baiardi, P.
    Ceci, A.
    Felisi, M.
    Cantarutti, L.
    Girotto, S.
    Sturkenboom, M.
    Baraldi, E.
    ACTA PAEDIATRICA, 2010, 99 (04) : 544 - 549
  • [35] Off-Label Use of Gastrointestinal Medications in the Intensive Care Unit
    Barletta, Jeffrey F.
    Lat, Ishaq
    Micek, Scott T.
    Cohen, Henry
    Olsen, Keith M.
    Haas, Curtis E.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2015, 30 (04) : 217 - 225
  • [36] An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics
    Bernardini, Roberto
    Toschi Vespasiani, Gaia
    Giannetti, Arianna
    MEDICINA-LITHUANIA, 2022, 58 (05):
  • [37] A Survey on the Off-Label Use of Atropine in the Treatment of Myopia in Italy
    Buzzonetti, Luca
    Navarra, Pierluigi
    OPHTHALMIC EPIDEMIOLOGY, 2025,
  • [38] Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials
    Johansson, P. I.
    VOX SANGUINIS, 2008, 95 (01) : 1 - 7
  • [39] Off-label use of anti-cancer drugs in India: To be or not to be!
    Gota, Vikram
    Patial, Pankaj
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (01) : 35 - 39
  • [40] THE OFF-LABEL USE OF MEDICATION: THE LATEST ON THE AVASTIN - LUCENTIS DEBACLE
    Jansen, Rita-Marie
    MEDICINE AND LAW, 2013, 32 (01): : 65 - 77